Compound information
- Natural Products
- ZC1350748
- Molecular Formula
- C19H21N5O
- Molecular Weight
- 335.174610292 g/mol
- Structure
-
- IUPAC Name
- 4-[(4-cyanophenyl)methyl]-N-(3-pyridyl)-1,4-diazepane-1-carboxamide
- InChI
- InChI=1S/C19H21N5O/c20-13-16-4-6-17(7-5-16)15-23-9-2-10-24(12-11-23)19(25)22-18-3-1-8-21-14-18/h1,3-8,14H,2,9-12,15H2,(H,22,25)
- InChI Key
- RFPYYJRJZDNEAG-UHFFFAOYSA-N
- SMILES
- N#Cc1ccc(CN2CCCN(C(=O)Nc3cccnc3)CC2)cc1
- Source
- ZINC000048262237
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 72.26 Å2 | LogP | 1.745 |
LogS | -2.836 | LogD | 1.89 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.086 | Pgp substrate | 0.312 |
HIA | 0.966 | F20 % | 0.983 |
F30 % | 0.704 | Caco-2 | -4.92 |
MDCK | -5.353 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.857 | PPB | 67.694 |
VD | 0.921 | Fu | 0.58 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.01 | CYP1A2 substrate | 0.723 |
CYP2A6 substrate | 0.783 | CYP2B6 substrate | 0.731 |
CYP2C19 inhibitor | 0.218 | CYP2C19 substrate | 0.76 |
CYP2C8 substrate | 0.824 | CYP2C9 inhibitor | 0.617 |
CYP2C9 substrate | 0.168 | CYP2D6 inhibitor | 0.163 |
CYP2D6 substrate | 0.999 | CYP2E1 substrate | 0.672 |
CYP3A4 inhibitor | 0.395 | CYP3A4 substrate | 0.969 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.822 | CL | 11.875 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.908 | Hepatotoxicity | 0.846 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.716 |
FDAMDD | 0.742 | Skin Sensitization | 0.972 |
Carcinogenicity | 0.008 | Eye Corrosion | 0.001 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.483 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.117 | IGC50 | 2.986 |
LC50FM | 0.465 | LC50DM | -4.258 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.441 | NR-AR-LBD | 0.223 |
NR-AhR | 0.299 | NR-Aromatase | 0.07 |
NR-ER | 0.327 | NR-ER-LBD | 0.327 |
NR-PPAR-gamma | 0.184 | SR-ARE | 0.698 |
SR-ATAD5 | 0.388 | SR-HSE | 0.128 |
SR-MMP | 0.028 | SR-p53 | 0.091 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.